These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21297338)
1. Solid gastric emptying mediated by the serotonin (5-HT)3 receptor in mice is a simple marker to predict emesis. Ando K; Takagi K J Toxicol Sci; 2011 Jan; 36(1):23-9. PubMed ID: 21297338 [TBL] [Abstract][Full Text] [Related]
2. Enhanced gastric retention of solid resin beads as a marker for emetic potential of agents in rats. Ando K; Takagi K; Tsubone H J Toxicol Sci; 2012; 37(3):549-53. PubMed ID: 22687994 [TBL] [Abstract][Full Text] [Related]
3. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Ozaki A; Sukamoto T Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662 [TBL] [Abstract][Full Text] [Related]
4. 5-HT3 receptors participate in CCK-induced suppression of food intake by delaying gastric emptying. Hayes MR; Moore RL; Shah SM; Covasa M Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R817-23. PubMed ID: 15191908 [TBL] [Abstract][Full Text] [Related]
5. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog. Yoshida N; Omoya H; Ito T J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032 [TBL] [Abstract][Full Text] [Related]
6. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). Sharma SS; Gupta YK J Ethnopharmacol; 1998 Aug; 62(1):49-55. PubMed ID: 9720611 [TBL] [Abstract][Full Text] [Related]
7. [Serotonin and anticancer drug-induced emesis]. Minami M; Endo T; Hamaue N; Hirafuji M Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719 [TBL] [Abstract][Full Text] [Related]
8. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents. Miyata K; Yamano M; Kamato T; Akuzawa S Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628 [TBL] [Abstract][Full Text] [Related]
9. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog. Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Malik NM; Liu YL; Cole N; Sanger GJ; Andrews PL Eur J Pharmacol; 2007 Jan; 555(2-3):164-73. PubMed ID: 17141213 [TBL] [Abstract][Full Text] [Related]
11. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Yamano M; Kamato T; Miyata K Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982 [TBL] [Abstract][Full Text] [Related]
12. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. Gullikson GW; Loeffler RF; Viriña MA J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288 [TBL] [Abstract][Full Text] [Related]
13. Effects of an Atractylodes lancea rhizome extract and a volatile component β-eudesmol on gastrointestinal motility in mice. Kimura Y; Sumiyoshi M J Ethnopharmacol; 2012 May; 141(1):530-6. PubMed ID: 22374082 [TBL] [Abstract][Full Text] [Related]
14. The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret. Rudd JA; Bunce KT; Naylor RJ Neuropharmacology; 1996 Jan; 35(1):91-7. PubMed ID: 8684601 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three preclinical models for nausea and vomiting assessment. Goineau S; Castagné V J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617 [TBL] [Abstract][Full Text] [Related]
16. The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents. Fioramonti J; Dupuy C; Dupuy J; Bueno L J Pharmacol Exp Ther; 1993 Sep; 266(3):1255-60. PubMed ID: 8371135 [TBL] [Abstract][Full Text] [Related]
17. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice. Haga K; Asano K; Inaba K; Morimoto Y; Setoguchi M Arch Int Pharmacodyn Ther; 1994; 328(3):344-55. PubMed ID: 7625886 [TBL] [Abstract][Full Text] [Related]
18. Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis. Miner WD; Sanger GJ; Turner DH Br J Cancer; 1987 Aug; 56(2):159-62. PubMed ID: 3311109 [TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats. Ito C; Isobe Y; Tsuchida K; Higuchi S Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630 [TBL] [Abstract][Full Text] [Related]
20. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs. Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]